Today: 23 April 2026
Marriott (MAR) stock jumps toward record high on luxury travel demand and credit-card fee outlook
11 February 2026
1 min read

Marriott (MAR) stock jumps toward record high on luxury travel demand and credit-card fee outlook

New York, Feb 11, 2026, 05:33 EST — Premarket

  • Marriott shares jumped last session after the company released its 2026 outlook, pointing to increased fee revenue.
  • Luxury travel held steady, but the company pointed to weaker trends among budget travelers.
  • Traders are watching for momentum in U.S. travel trends, with crucial U.S. inflation numbers set for release Friday.

Marriott International shares surged 8.5% on Tuesday, ending the session at $359.35 after touching a new all-time high of $363.54. The rally followed the company’s outlook for a 35% jump in co-branded credit card fees. Marriott is projecting RevPAR growth of 1.5% to 2.5% in 2026, with the FIFA World Cup expected to tack on another 30 to 35 basis points to the global figure. CEO Anthony Capuano cited “almost insatiable demand for luxury” abroad, and Jefferies’ David Katz flagged the fee guidance as “higher than expected.” Reuters

This shift puts hotel stocks front and center as a gauge of just how much consumers are willing to shell out for travel in 2026. Marriott’s remarks only highlighted what investors have been tracking—luxury travelers are still opening their wallets, but those looking for deals aren’t keeping pace.

Marriott’s earnings update showed global RevPAR up 1.9% in the fourth quarter; international properties saw a 6.1% bump, while the U.S. and Canada slipped 0.1%. CEO Capuano pointed to reduced business transient demand tied to an extended U.S. government shutdown, though luxury segments bucked the trend—RevPAR there jumped over 6% for the quarter. Marriott wrapped up 2025 with a record pipeline approaching 610,000 rooms, bought back 3.5 million shares for $1.0 billion last quarter, and is targeting capital returns topping $4.3 billion in 2026. The outlook, Marriott noted, doesn’t reflect any hit from its ongoing U.S. co-branded card contract negotiations.

On Tuesday, Marriott filed an 8-K with the SEC, tacking on its earnings press release.

The company put out its annual 10-K for the year ended Dec. 31, 2025—a filing that investors typically scour for changes in risk disclosures, tweaks to fee details, loyalty economics, and leverage.

Marriott’s jump sent hotel stocks higher last session. Hilton tacked on 3.1%, hitting a fresh 52-week high, and Hyatt advanced 5.9%. Investors pushed into travel and leisure names, shrugging off a mixed market backdrop.

The rally doesn’t leave much margin for error if U.S. demand remains uneven. A miss on business travel numbers or a tougher result from the U.S. credit-card negotiations would shift the pressure back onto room-rate increases.

Eyes turn next to Friday, Feb. 13, when January’s U.S. consumer price inflation lands at 8:30 a.m. ET—a figure with the power to jolt rate bets and ripple into discretionary spend. Marriott’s immediate questions are more straightforward: Will luxury demand stick through spring, and does management finally pin down a date on the U.S. co-branded card renegotiation?

Stock Market Today

  • Pitney Bowes (PBI) Upgraded to Zacks Rank #2 Buy on Rising Earnings Forecasts
    April 23, 2026, 1:35 PM EDT. Pitney Bowes (PBI) has been upgraded to a Zacks Rank #2 (Buy) driven by an upward revision in earnings estimates, highlighting improved expectations for the company's future profits. The Zacks Rank system, which reflects changes in consensus earnings per share (EPS) estimates from analysts, correlates strongly with near-term stock price movements. Institutional investors often adjust valuations based on these earnings revisions, influencing stock price trends. Pitney Bowes' anticipated EPS of $1.52 for fiscal 2026 underlines positive business momentum. The upgrade suggests investors may see buying opportunities as earnings outlooks improve, reinforcing the value of tracking earnings estimate revisions in stock selection.

Latest article

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

IREN Stock Jumps as AI Cloud Bet Meets $6 Billion Dilution Test

23 April 2026
IREN shares jumped 7.3% to $51.94 in New York Thursday amid debate over its shift from bitcoin mining to AI cloud services. The company plans to deploy 150,000 Nvidia GPUs by late 2026 and reported $2.8 billion in cash as of January. AI cloud revenue remains small compared to bitcoin mining, with $17.3 million last quarter. IREN can sell up to $6 billion in stock under a new SEC filing.
Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

Hims Adds Lilly’s Zepbound and Foundayo as GLP-1 Price Fight Moves Online

23 April 2026
Hims & Hers Health said Thursday its providers can now send prescriptions for Eli Lilly’s Zepbound and Foundayo to LillyDirect, expanding branded obesity drug options on its platform. The move follows a similar deal with Novo Nordisk in March. Hims listed Foundayo from $149 a month and Zepbound from $299. The company previously stopped advertising compounded GLP-1s amid tighter U.S. regulations.
Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

Warren Buffett Successor Greg Abel Tightens Grip on Berkshire Hathaway Portfolio, Pushes New Money Into Japan

23 April 2026
Greg Abel now controls about 94% of Berkshire Hathaway’s $300 billion stock portfolio after Todd Combs’ departure, consolidating authority more than Warren Buffett had planned. Abel has kept major U.S. holdings largely intact but increased investments in Japanese firms, including a new $1.8 billion stake in Tokio Marine. Recent portfolio trims, such as Apple and Amazon, reflect Buffett’s last quarter in charge.
Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive
Previous Story

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view
Next Story

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view

Go toTop